NCT00005942

Liposomal Daunorubicin and SU5416 in Treating Patients With Hematologic Cancer That Has Not Responded to Initial Therapy

Public trial-level signal summary for this oncology Phase 2 record.

Record overview

Status and phase

Status: COMPLETED

Phase: PHASE1, PHASE2

Sponsor: National Cancer Institute (NCI)

Condition: Chronic Myelomonocytic Leukemia, Previously Treated Myelodysplastic Syndromes, Recurrent Adult Acute Myeloid Leukemia, Refractory Anemia With Excess Blasts, Refractory Anemia With Excess Blasts in Transformation

Signal summary

Public flags

Status signal: Low Signal

Timeline signals: stale_update_signal

Results signal: Completed No Results Found Signal

Operational burden: None

Stopped reason

Context when available

No stop reason available in the current public record.